Combined hormonal oral contraception and risk of venous thromboembolism (VTE)
Bayer HealthCare Pharmaceuticals has just introduced a new $20 million advertising campaign for Yaz, the most popular birth control pill in the United States.
But the television ads, now running during prime-time shows like “Grey’s Anatomy” and on cable networks, are not typical spots promoting the benefits of a prescription drug. Instead, they warn that nobody should take Yaz hoping that it will also cure pimples or premenstrual syndrome.
As part of an unusual crackdown on deceptive consumer drug advertising, the Food and Drug Administration and the attorneys general of 27 states have required Bayer to run these new ads to correct previous Yaz marketing....
The oral contraceptives Yaz and Yasmin are the top-selling pharmaceutical line for Bayer HealthCare, largely as a result of marketing that presents them as much more than mere pregnancy prevention.
Yaz, in particular, the top-selling birth control pill in the United States, owes much of its popularity to multimillion-dollar ad campaigns that have promoted the drug as a quality-of-life treatment to combat acne and severe premenstrual depression.
Yaz, a newer sister drug to Yasmin, contains less estrogen. The franchise had worldwide sales of about $1.8 billion last year, based on Bayer’s successful positioning of Yasmin and Yaz as the go-to drug brands for women under 35.
But recently, the Yaz line’s image has been clouded by concerns from some researchers, health advocates and plaintiffs’ lawyers. They say that the drugs put women at higher risk for blood clots, strokes and other health problems than some other birth control pills do....
Did You Know the FDA Recalled Bayer's Yaz Contraceptive? Neither Did Anyone Else
BY JIM EDWARDS
UPDATED ON: MAY 6, 2010 / 4:22 PM / MONEYWATCH
In November 2012, ABC News reported Bayer, the manufacturer of Yaz, a birth control pill, settled Yaz lawsuit claims at a fast pace. Bayer appears to be taking the approach to compensate those injured and put the situation to rest.
RD Legal Funding issued a press release on the Yaz or Yasmin birth control pill allegedly having caused people to suffer blood clots. ABC News reported the pill also caused individuals DVT, stroke or Pulmonary Embolism.
The Yaz Resource Center cautions victims to seek a lawyer with experience in defective drug litigation, and recommends people engage lawyers and law firms who have already settled Yaz lawsuits. According to the Yaz Lawsuit Center, Yaz lawsuits are handled on an individual basis, rather than as a single Yaz class action lawsuit. A class action lawsuit bundles together cases against a common defendant and if successful, a court grants a settlement that is equally split among individual class members according to predetermined calculations....
Yaz Birth Control - Yaz Side Effects, FDA Warning & Lawsuits
History of Yaz and Yasmin in the United States:
2001 – The FDA approves Yasmin, the first “fourth generation” birth control pill, which contains the hormone dropsirenone. Dropsirenone is allegedly responsible for Yaz side effects including dangerous blood clots and gallbladder problems.
March 2006 – The FDA approves Yaz for the prevention of pregnancy.
October 2006 – The FDA approves Yaz for the treatment of PMDD, a severe form of PMS. Yaz is not approved to treat ordinary PMS.
January 2007 – Yaz is approved to treat moderate acne.
October 2008 – The FDA sends a warning letter to Bayer about its marketing campaign, which caused consumers to believe that Yaz was effective for the treatment of PMS and for all stages of acne and which understated and obscured the risks of blood clots and other serious Yaz side effects.
February 2009 – Bayer HealthCare spends $20 million on advertisements to comply with FDA orders to inform the public about the actual indications and risks of Yaz.
April 2010 – The FDA updates the Yaz warning label with additional information about the possible risks of serious blood clots and vascular problems.
March 2011 – The FDA updates the labels on Yaz and other oral contraceptives containing dropsirenone to reflect new information about the risks of blood clots.
December 2011 – An FDA advisory panel decides in a 21-5 vote that the product warnings on Yaz are still inadequate and do not inform consumers about potentially fatal side effects that may lead to deep vein thrombosis, stroke or pulmonary embolism.
Yaz Birth Control: Uses, Dosages, Interactions and Warnings
Yaz Lawsuits | Blood Clot, Heart Attack & Stroke Claims
Over 19,000 Yaz claims were resolved through multidistrict litigation in United States District Court for the Southern District of Illinois.